Drug Shortage Report for TEVA-BUDESONIDE
Report ID | 138291 |
Drug Identification Number | 02465957 |
Brand name | TEVA-BUDESONIDE |
Common or Proper name | BUDESONIDE INH 0.5MG/ML 2ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 0.5MG |
Dosage form(s) | SUSPENSION |
Route of administration | INHALATION INHALATION |
Packaging size | 10pk |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-04-28 |
Estimated end date | 2021-08-31 |
Actual end date | 2021-08-06 |
Shortage status | Resolved |
Updated date | 2021-08-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-04-29 | English | Compare |
v2 | 2021-04-29 | French | Compare |
v3 | 2021-05-10 | English | Compare |
v4 | 2021-05-10 | French | Compare |
v5 | 2021-06-03 | English | Compare |
v6 | 2021-06-03 | French | Compare |
v7 | 2021-06-24 | English | Compare |
v8 | 2021-06-24 | French | Compare |
v9 | 2021-07-08 | English | Compare |
v10 | 2021-07-08 | French | Compare |
v11 | 2021-08-05 | English | Compare |
v12 | 2021-08-05 | French | Compare |
v13 | 2021-08-06 | English | Compare |
v14 | 2021-08-06 | French | Compare |
v15 | 2021-08-07 | English | Compare |
Showing 1 to 15 of 15